SCHEMBL1357151

SCHEMBL1357151

CCCCCCCCNC(=O)OC(N)=O

nearest known ligand 0.66

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 6/20 0.66
ACHE P22303 7/20 0.52
CASP2 P42575 1/20 0.50
MGLL Q99685 1/20 0.47
FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28990518 1.00 EPHX1 (0.66) EPHX1ACHECASP2MGLLFAAH
SCHEMBL6420182 0.82 EPHX1 (0.68) EPHX1ACHECASP2FAAH
SCHEMBL10512790 0.82 EPHX1 (0.68) EPHX1ACHECASP2MGLLFAAH
SCHEMBL6420325 0.82 EPHX1 (0.68) EPHX1ACHECASP2FAAH
SCHEMBL6420176 0.82 EPHX1 (0.68) EPHX1ACHECASP2FAAH
SCHEMBL26913612 0.81 EPHX1 (0.61) EPHX1ACHECASP2
SCHEMBL8768404 0.80 EPHX1 (0.70) EPHX1ACHECASP2FAAH
SCHEMBL28103318 0.80 EPHX1 (0.70) EPHX1ACHECASP2FAAH
SCHEMBL18190246 0.80 EPHX1 (0.70) EPHX1ACHECASP2FAAH
SCHEMBL28204572 0.80 EPHX1 (0.70) EPHX1ACHECASP2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110288230-A1 METHOD FOR PREPARING POLYHYDROXY-URETHANES RHODIA OPERATIONS (FR) 2011-11-24 US disclosed
US-8017719-B2 Method for preparing polyhydroxy-urethanes RHODIA OPERATIONS (FR) 2011-09-13 US disclosed
US-20090312502-A1 Method for preparing polyhydroxy-urethanes RHODIA OPERATIONS (FR) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288230-A1 METHOD FOR PREPARING POLYHYDROXY-URETHANES UROD, HPD, ALKBH3 EPHX1 999/4885ACHE 3441/4885CASP2 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.